Troutman Pepper Locke senior associate Ryan Last explains when markets will start to significantly react to the upcoming pharma tariffs. In April of this year, President Trump announced plans to ...
Germany's drug pricing reforms clash with US MFN policy ambitions. Explore why Europe's largest pharma market holds the key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results